| Schedule of Segment Reporting Information |
The following table summarizes select operating results information for each reportable segment (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma |
|
$ |
21,046 |
|
|
$ |
19,718 |
|
|
$ |
60,105 |
|
|
$ |
56,063 |
|
Interventional Dry Eye |
|
|
3,877 |
|
|
|
188 |
|
|
|
7,905 |
|
|
|
915 |
|
Total |
|
|
24,923 |
|
|
|
19,906 |
|
|
|
68,010 |
|
|
|
56,978 |
|
Cost of goods sold |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma cost of goods sold |
|
|
2,688 |
|
|
|
2,592 |
|
|
|
7,865 |
|
|
|
7,662 |
|
Interventional Glaucoma tariff recovery |
|
|
— |
|
|
|
— |
|
|
|
(1,231 |
) |
|
|
— |
|
Interventional Dry Eye cost of goods sold |
|
|
815 |
|
|
|
117 |
|
|
|
1,738 |
|
|
|
438 |
|
Interventional Dry Eye tariff recovery |
|
|
— |
|
|
|
— |
|
|
|
(135 |
) |
|
|
— |
|
Total cost of goods sold |
|
|
3,503 |
|
|
|
2,709 |
|
|
|
8,237 |
|
|
|
8,100 |
|
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma |
|
|
18,358 |
|
|
|
17,126 |
|
|
|
53,471 |
|
|
|
48,401 |
|
Interventional Dry Eye |
|
|
3,062 |
|
|
|
71 |
|
|
|
6,302 |
|
|
|
477 |
|
Total |
|
|
21,420 |
|
|
|
17,197 |
|
|
|
59,773 |
|
|
|
48,878 |
|
Operating expenses |
|
|
(27,548 |
) |
|
|
(25,102 |
) |
|
|
(82,201 |
) |
|
|
(82,308 |
) |
Investment income |
|
|
692 |
|
|
|
965 |
|
|
|
2,111 |
|
|
|
3,139 |
|
Interest expense |
|
|
(1,312 |
) |
|
|
(1,306 |
) |
|
|
(3,869 |
) |
|
|
(3,853 |
) |
Other income (expense), net |
|
|
(51 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
|
(118 |
) |
Loss before income taxes |
|
$ |
(6,799 |
) |
|
$ |
(8,248 |
) |
|
$ |
(24,185 |
) |
|
$ |
(34,262 |
) |
|